MedTrace Logo

Supernormal Oxygen Delivery for Patients With Severe Burns

NCT05241912 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-02-16

No results posted yet for this study

Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

Conditions

  • Burn Surgery
  • Dobutamine

Interventions

DRUG

Dobutamine

administration of dobutamine 0.01 - 0.04 U/min after induction of anesthesia to maintain oxygen delivery

Sponsors & Collaborators

  • Guangzhou Red Cross Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241912 on ClinicalTrials.gov